The correlation between the costs and clinical benefits of PD-1/PD-L1 inhibitors in malignant tumors: An evaluation based on ASCO and ESMO frameworks

Background: Life expectancy for patients with malignant tumors has been significantly improved since the presence of the programmed cell death protein-1/programmed cell death protein ligand-1 (PD-1/PD-L1) inhibitors in 2014, but they impose heavy financial burdens for patients, the healthcare system...

Full description

Saved in:
Bibliographic Details
Main Authors: Shen Lin (Author), Yaping Huang (Author), Liangliang Dong (Author), Meiyue Li (Author), Yahong Wang (Author), Dian Gu (Author), Wei Wu (Author), Dongni Nian (Author), Shaohong Luo (Author), Xiaoting Huang (Author), Xiongwei Xu (Author), Xiuhua Weng (Author)
Format: Book
Published: Frontiers Media S.A., 2023-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available